Vedolizumab for perianal fistulizing Crohn’s disease: systematic review and meta-analysis

BACKGROUND/AIMS: Perianal fistulas are a debilitating manifestation of Crohn’s disease (CD). Despite the advent of anti-tumor necrosis factor (anti-TNF) therapy, the medical management of fistulizing CD continues to be challenged by unmet needs. We conducted a systematic review and meta-analysis of...

Descripción completa

Detalles Bibliográficos
Autores principales: Ayoub, Fares, Odenwald, Matthew, Micic, Dejan, Dalal, Sushila R., Pekow, Joel, Cohen, Russell D., Rubin, David T., Sakuraba, Atsushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Association for the Study of Intestinal Diseases 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9081994/
https://www.ncbi.nlm.nih.gov/pubmed/35124951
http://dx.doi.org/10.5217/ir.2021.00091

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9081994/
https://www.ncbi.nlm.nih.gov/pubmed/35124951
http://dx.doi.org/10.5217/ir.2021.00091

Ejemplares similares